You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

COLESTIPOL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Colestipol Hydrochloride patents expire, and when can generic versions of Colestipol Hydrochloride launch?

Colestipol Hydrochloride is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, and Zydus Pharms. and is included in five NDAs.

The generic ingredient in COLESTIPOL HYDROCHLORIDE is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Colestipol Hydrochloride

A generic version of COLESTIPOL HYDROCHLORIDE was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for COLESTIPOL HYDROCHLORIDE?
  • What are the global sales for COLESTIPOL HYDROCHLORIDE?
  • What is Average Wholesale Price for COLESTIPOL HYDROCHLORIDE?
Summary for COLESTIPOL HYDROCHLORIDE
US Patents:0
Applicants:4
NDAs:5
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 20
Clinical Trials: 11
Patent Applications: 332
What excipients (inactive ingredients) are in COLESTIPOL HYDROCHLORIDE?COLESTIPOL HYDROCHLORIDE excipients list
DailyMed Link:COLESTIPOL HYDROCHLORIDE at DailyMed
Drug patent expirations by year for COLESTIPOL HYDROCHLORIDE
Recent Clinical Trials for COLESTIPOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ain Shams UniversityPhase 4
Instituto Nacional de Salud Publica, MexicoPhase 3
Laboratorios Grossman, S.A.Phase 3

See all COLESTIPOL HYDROCHLORIDE clinical trials

Pharmacology for COLESTIPOL HYDROCHLORIDE
Drug ClassBile Acid Sequestrant
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for COLESTIPOL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for COLESTIPOL HYDROCHLORIDE

US Patents and Regulatory Information for COLESTIPOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277-001 May 2, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Edenbridge Pharms COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 217667-001 Aug 16, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277-002 May 2, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 216517-001 Mar 10, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 215223-001 Mar 10, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 077510-001 Oct 24, 2006 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.